Isomorphic Labs pushes its first AlphaFold-derived drugs closer to human trials
Isomorphic Labs, the DeepMind spinoff built to commercialise AlphaFold's protein structure prediction breakthroughs into actual drugs, has advanced several of its internally developed and partner-collaborated drug candidates further through preclinical development this year, a milestone the company
Source: Reuters